ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 54 filers reported holding ADC THERAPEUTICS SA in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $958,416 | -42.7% | 1,068,468 | +37.3% | 0.54% | -41.4% |
| Q2 2023 | $1,672,700 | +12.9% | 778,000 | +2.4% | 0.93% | -9.3% |
| Q1 2023 | $1,482,000 | +29.7% | 760,000 | +155.5% | 1.02% | -9.4% |
| Q4 2022 | $1,142,400 | +80.5% | 297,500 | +1044.2% | 1.13% | +556.4% |
| Q2 2021 | $633,000 | +52.5% | 26,000 | +52.9% | 0.17% | +22.9% |
| Q1 2021 | $415,000 | +270.5% | 17,000 | +385.7% | 0.14% | +197.9% |
| Q4 2020 | $112,000 | +239.4% | 3,500 | +250.0% | 0.05% | +193.8% |
| Q3 2020 | $33,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |